Incannex Secures US Patent for Sleep Apnea Drug Candidate IHL-42X
The granted patent protects the proprietary oral combination therapy through at least 2040, as the company prepares to launch its Phase 2 dose optimization study.
The granted patent protects the proprietary oral combination therapy through at least 2040, as the company prepares to launch its Phase 2 dose optimization study.
The prescription-only reusable EPAP device offers two therapeutic back pressure settings to treat obstructive sleep apnea.
This guide compares EPAP devices on specifications including sizes, materials, warranty, payor coverage, cleaning instructions, and supporting studies.
This CSTE quiz covers biopsychosocial approaches to sleep health, innovative uses of home sleep testing for therapy monitoring, and updated perspectives on restless legs syndrome.
The updated kit features an overnight wellness sensor to track sleep patterns in older adults without the use of cameras or wearables.
Preparation at home, child-friendly environments, and experienced techs can improve the in-lab polysomnography experience for the youngest patients, as well as those with sensitivities or anxiety.
The oral appliance developer aims to advance dental sleep medicine through investigator-initiated research funding and a new real-world clinical case library.